Liraglutide (Victoza) |
A diabetes drug |
Cognitive benefits, reduced inflammatory response and an increase of young neurons |
319 |
β-Sheet breaker |
Binds Aβ and destabilizes its structure |
Inhibits oligomer or amyloid formation |
320,321 |
MRS2481 |
Small molecule blocker of Abeta channel |
Protects neurons from Aβ induced toxicity |
322 |
MRS2485 |
Small molecule blocker of Abeta channel |
Protects neurons from Aβ induced toxicity |
322 |
Bexarotene |
Inhibits the binding of cholesterol to Aβ and prevents calcium-permeable amyloid pore formation |
Anti-Alzheimer |
323 |
Verapamil |
Voltage-gated calcium channel blocker |
Protects neurons from Aβ-induced toxicity |
324 |
Diltiazem |
Voltage-gated calcium channel blocker |
Protects neurons from Aβ-induced toxicity |
324 |
Isradipine |
Voltage-gated calcium channel blocker |
Protects neurons from Aβ-induced toxicity |
324 |
Nimodipine |
Voltage-gated calcium channel blocker |
Protects neurons from Aβ-induced toxicity |
324 |
Huperzine A |
A novel lycopodium alkaloid |
Neuroprotective effects |
326,327 |
Arctigenin |
Inhibits Aβ production and promotes Aβ clearance |
Ameliorates memory impairment |
330 |
2,2′,4′-trihydroxychalcone (TDC) |
Represses beta-cleavage of APP and production of Aβ |
Improves the memory impairment |
328 |
Bis(7)-cognitin |
Inhibition of AChE, NMDA receptor, nitric oxide synthase, and amyloid precursor protein/beta-amyloid cascade |
Neuroprotective effects |
329 |
Clioquinol |
Inhibits metal-ion binding to Aβ |
Inhibits Aβ deposition |
331 |
Idalopirdine |
5-HT6 receptor antagonist |
In combination with a cholinesterase inhibitor may increase the cognitive function |
325 |
Azeliragon |
RAGE inhibitor |
Mediates transport of the Aβ peptide into the brain |
332 |
Encenicline |
α7-nAChR inhibitor |
Restores memory function |
333 |
Nilvaldipine |
Calcium antagonist |
Cognition improvement |
334 |